Pb-212-ADVC001
212Pb-ADVC001 is an alpha-emitting PSMA targeting radiolabeled molecule developed in [...]
Lu-177-XT033
177Lu-XT033 is a PSMA targeting radiotherapeutic developed for the treatment [...]
Lu-177-HTK03170
177Lu-HTK03170 is the therapeutic 177Lu-labeled analogue of 68Ga-HTK03149, itself based [...]
Ac-225-FPI-2265
225Ac-FPI-2265 (225Ac-PSMA-I&T) is another alpha emitter analogue of the marketed [...]
Lu-177-PSMA-ALB-56
177Lu-PSMA-ALB-56 is a radiolabeled PSMA analogue developed for prostate cancer [...]
Lu-177-Ludotadipep
177Lu-Ludotadipep (177Lu-FC705) is a 177Lu-labeled analogue of 177Lu-Vipivotide targeting PSMA. [...]
Tb-161-PSMA-I&T
161Tb-PSMA-I&T is a terbium analogue of 177Lu-Vipivotide tetraxetan and the [...]
Lu-177-rhPSMA-10.1
rhPSMA (radiohybrid PSMA) is a prostate specific membrane antigen labeled [...]
Lu-177-Rosopatamab
177Lu-Rosopatamab (177Lu-J591, 177Lu-TLX591, 177Lu-J591, 177Lu-ATL-101) is the Lutetium-177 labeled [...]
Lu-177-Vipivotide tetraxetan (Pluvicto™)
177Lu-Vipivotide tetratexan (177Lu-PSMA-617) is a 177Lu labeled peptide developed [...]